Syngen Biotech Co.,Ltd. (8279.TWO)

TWD 118.5

(-0.42%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Total Assets 3.1 Billion 3.07 Billion 2.41 Billion 2.12 Billion -
Total Current Assets 1.13 Billion 1.11 Billion 1.01 Billion 1.01 Billion -
Cash And Short Term Investments 366.89 Million 246.05 Million 314.8 Million 423.41 Million -
Cash and Cash Equivalents 366.89 Million 246.05 Million 314.8 Million 423.41 Million -
Short Term Investments -1.35 Million - - - -
Net Receivables 387.79 Million - - - -
Inventory 348.98 Million 369.34 Million 291.96 Million 259.78 Million -
Other Current Assets 387.79 Million - - - -
Total Non-Current Assets 1.97 Billion 1.95 Billion 1.39 Billion 1.11 Billion -
Net PPE 1.57 Billion 1.57 Billion 1.04 Billion 1.04 Billion -
Good Will And Intangible Assets 24.12 Million 22.96 Million 23.42 Million 27.31 Million -
Good Will - - - - -
Intangible Assets 24.12 Million - - - -
Long-Term Investments 333.09 Million - - - -
Tax Assets 17.44 Million 16.2 Million 12.31 Million 10.38 Million -
Other Non Current Assets 27.39 Million 343.37 Million 318.03 Million 23.59 Million -
Other Assets - - - - -
Total Liabilities 974.63 Million 1.07 Billion 644.16 Million 500.74 Million 19 Thousand
Total Current Liabilities 584.57 Million 719.47 Million 418.61 Million 311.99 Million -
Account Payables 83.18 Million 62.69 Million 124.82 Million 67.04 Million -
Tax Payables 62.06 Million 76.98 Million 58.38 Million 28.12 Million -
Short Term Debt 295.68 Million 430.59 Million 125.72 Million 137.65 Million -
Deferred Revenue 20.03 Million - - - -
Other Current Liabilities 185.66 Million 226.17 Million 168.06 Million 107.29 Million -
Total Non Current Liabilities 390.05 Million 359.86 Million 225.55 Million 188.74 Million 19 Thousand
Long-Term Debt 386.07 Million 355.92 Million 222.38 Million 186.16 Million -
Deferred Revenue Non Current -3.97 Million - - - -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 3.97 Million - - - 19 Thousand
Other Liabilities - - - - -
Total Equity 2.13 Billion 1.99 Billion 1.77 Billion 1.62 Billion -
Stock Holders Equity 2.13 Billion 1.99 Billion 1.77 Billion 1.62 Billion -
Common Stock 271 Million 271 Million 271 Million 271 Million -
Retained Earnings 1.08 Billion 980.93 Million 790.33 Million 668.72 Million -
Accumulated other comprehensive income 771.86 Million - - - -
Common Stock Equity 2.13 Billion 1.99 Billion 1.77 Billion 1.62 Billion -
Capital Lease Obligation 176.48 Million 188.77 Million 186.08 Million 200.27 Million -
Total Investments 331.74 Million 313.74 Million 293.55 Million 2.7 Million -
Total Debt 681.76 Million 786.52 Million 348.11 Million 323.82 Million -
Net Debt 314.87 Million 540.47 Million 33.31 Million -99.59 Million -

Balance Sheet Charts